About the fund
The Agape Fund allocates philanthropic capital to advance medical research in neurodegenerative diseases and improve care delivery systems for the neurodivergent community. We are a mission-driven organization dedicated to supporting the most impactful, evidence-based initiatives that serve individuals and families across this spectrum of need.
Our work spans funding breakthrough research, designing and delivering inclusive therapy programs, and launching pilot studies that test and scale innovative models of care. We believe in cross-sector collaboration, scientific rigor, and community engagement as essential tools for creating long-term, systemic impact.
The Agape Fund is a 501(c)(3) public charity (EIN: 99-4102585), classified under IRS Section 170(b)(1)(A)(vi). We also operate a Donor-Advised Fund (DAF) platform to enable aligned philanthropists to participate in our mission and co-invest in our grantmaking efforts.
Thomas and his siblings (2007).
Thomas Byrne
The Agape Fund was inspired by our brother Thomas, diagnosed with Down syndrome.
As he grew, it became clear that families navigating neurological conditions often encounter fragmented care, limited research pathways, and programs that are difficult to access or sustain. His journey revealed a need in our system for stronger, more inclusive pathways of care.
Our work is rooted in serving those whose voices are often quiet but deeply deserving of being heard, supported, and uplifted. Inspired by Thomas, we are committed to championing individuals and families facing complex medical or neurodivergent challenges, ensuring they have access to the research, care, and community they need to thrive.